FlyPark: A High-Throughput Drosophila Platform for Parkinson's Disease Drug Screening

2027 · 2027 Competition

School: School of Biomedical Engineering and Science
Category: Research ScientistsPrimary

Project Overview

One Liner: An improved method to scale reflex observation in Drosophila

Company: Drexel University

Abstract

Parkinsons Disease (PD) is the second most common neurodegenerative disease worldwide, and symptom-mitigating care imposes an economic burden of more than $80 billion in the United States. Despite widespread public recognition, there is still no cure for PD. Drug screening is a critical part of PD research, allowing biological drug responses to be studied for safety and efficacy before human trials are considered. Drosophila (Fruit flies) are commonly used in PD research for their ease of care and genetic similarities to human PD. FlyPark is an automated Drosophila observation platform designed to improve throughput compared to traditional methods that involve manual tethering, which can be a lengthy and difficult process. The handling and observation of flies will be automated to standardize data collection and improve reproducibility of Drosophila-based drug studies.

No video available.

Screenshots

0 image(s)

No screenshots uploaded yet.

Team Members

Audrey Greenip
Lead
Kathia Tronconi
Saniyah Paden-Closs
Saniyah Paden-Closs
Thomas Mikhael
Nehir Uke

Advisors

Vikas Bhandawat

Stakeholders

Tom Ruggierio